Clinical Development / About Type 1 Diabetes
Type 1 diabetes (T1D) is a chronic autoimmune disease in which the immune system's T cells mistakenly attack the body's own insulin-producing beta cells, leaving the body unable to produce insulin, a hormone necessary for the body to provide energy. People living with T1D are dependent on insulin, administered via injection or pump, to survive.
Managing type 1 diabetes requires a strict regimen of insulin and food intake, exercise, and other activities. There is no cure for type 1 diabetes, and over time it can lead to serious complications including stroke, heart disease, kidney disease and amputation.
Type 1 diabetes and celiac disease are both autoimmune disorders linked to the human leukocyte antigen (HLA) gene complex and approximately 8% of people living with celiac disease also live with type 1 diabetes1.
ImmusanT is rapidly advancing the development of a therapeutic vaccine for type 1 diabetes and has received support from the JDRF T1D Fund. To view ImmusanT’s list of programs, please visit the pipeline page.